Winton Group’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-3,046
| Closed | -$758K | – | 1452 |
|
|
2020
Q3 | $758K | Sell |
3,046
-3,770
| -55% | -$938K | 0.02% | 937 |
|
|
2020
Q2 | $2.37M | Sell |
6,816
-701
| -9% | -$244K | 0.06% | 569 |
|
|
2020
Q1 | $2.01M | Sell |
7,517
-9,367
| -55% | -$2.51M | 0.05% | 574 |
|
|
2019
Q4 | $5.47M | Buy |
16,884
+13,561
| +408% | +$4.39M | 0.08% | 433 |
|
|
2019
Q3 | $908K | Buy |
3,323
+2,837
| +584% | +$775K | 0.01% | 878 |
|
|
2019
Q2 | $259K | Buy |
486
+36
| +8% | +$19.2K | 0.01% | 945 |
|
|
2019
Q1 | $227K | Sell |
450
-230
| -34% | -$116K | ﹤0.01% | 912 |
|
|
2018
Q4 | $335K | Buy |
680
+196
| +40% | +$96.6K | 0.01% | 622 |
|
|
2018
Q3 | $443K | Sell |
484
-28
| -5% | -$25.6K | 0.01% | 677 |
|
|
2018
Q2 | $375K | Buy |
512
+149
| +41% | +$109K | 0.01% | 738 |
|
|
2018
Q1 | $579K | Buy |
+363
| New | +$579K | 0.02% | 704 |
|